跳至主要内容
临床试验/IRCT20180619040161N1
IRCT20180619040161N1招募中3 期

Effect of citalopram as an adjuvant with atypical antipsychotics on psychotic symptoms in chronic schizophrenia

Oroumia University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Diagnosis of Schizophrenia according to DSM5 criteria and clinical interview by psychiatrist
  • Age range 15-65 years
  • Ability to provide informed consent and cooperation with study procedures
  • At least, 5 years history of schizophrenia
  • Participants needed to be currently taking an Atypic antipsychotic agent for 6 month prior to study
  • Based on the HAM-D scale, having a score of less than 20

排除标准

  • Patients under treatment with clozapin
  • Any sever mental disorder(major depressive disorder, psychotic symptoms, manic phase symptoms,…)
  • Renal, hepatic, thyroid, or hematological disorder; and any sever and chronic medical disorder
  • Pregnancy or lactation
  • Individuals on antidepressants treatment for other indications (Tricyclic antidepressant , MAO inhibitor ,Selective serotonine reuptake inhibitor,… )for 1 month prior to randomization
  • Prior history of convulsion , stroke and head trauma
  • History of mental retardation (IQ less than 70)
  • History of substance abuse or dependence within 6months prior to study participation (except nicotine or caffeine dependence)

研究者

发起方
Oroumia University of Medical Sciences

相似试验